22 Jun 2010 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Enters Agreement to Develop and Commercialize Antigen-Based Therapy for Type 1 Diabetes
22 Jun 2010 Inovio Pharmaceuticals' Optimized DNA Vaccine Demonstrates Significant Advantages in Non-Human Primates Compared to Leading Viral Vector Based Vaccine
21 Jun 2010 Stallergenes: Staloral(R) Mites 300 Clinical Study in China: Efficacy is Demonstrated
17 Jun 2010 Mymetics' Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania
17 Jun 2010 Merck KGaA Resumes Stimuvax Clinical Program in Lung Cancer
16 Jun 2010 IRX Therapeutics Raises $8 Million to Develop Therapeutic Vaccines for Cancer and Viral Diseases
16 Jun 2010 Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
15 Jun 2010 Inovio Pharmaceuticals Immunizes First Subject in U.S. Influenza DNA Vaccine Clinical Trial
15 Jun 2010 SCIB1 Immunobody DNA Vaccine Phase I Trial Commences
10 Jun 2010 tellar Biotechnologies Beginning Preclinical Testing
08 Jun 2010 Argos Therapeutics Presents Positive Phase 2 Data for Arcelis Dendritic Cell-based Immunotherapy in Advanced RCC at ASCO
07 Jun 2010 Exceptional Survival Data, Lower Costs Key to the Competitive Advantage of DCVax(R) - Northwest Biotherapeutics' Vaccine for Multiple Cancers
07 Jun 2010 Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine
07 Jun 2010 Landmark Study Confirms GRAZAX(R) as the Only Grass Allergy Immunotherapy Tablet to Show Sustained Effect 2 Years After Treatment Completion
04 Jun 2010 Scancell Enters Strategic Collaboration with ImmuneRegen BioSciences
03 Jun 2010 ImmunoCellular Therapeutics' ICT-107 Demonstrates 80 Percent Survival at 2 Years in Phase I Study of Newly Diagnosed Glioblastoma Patients
27 May 2010 ARCA Launches First Therapeutic Trial with GeoVax Vaccine
26 May 2010 Pevion Biotech and CEVEC Pharmaceuticals Sign Exclusive License Option Agreement
26 May 2010 Advaxis Doses First Cervical Dysplasia Clinical Trial Patient
25 May 2010 Vical Collaborators Receive Grant to Pursue Novel CMV Vaccine Strategies
21 May 2010 Placebo-controlled phase II study shows CYT003-QbG10 is safe and efficacious for the treatment of allergic asthma
20 May 2010 Vaxon Biotech Successfully Completes Its Phase I/II Trial Of Vx-001 Cancer Vaccine, Phase III Ready To Start In NSCLC
20 May 2010 Encouraging Data Presented on Oncophage Vaccine at International Conference on Brain Tumor Research and Therapy
19 May 2010 Inviragens Dengue Vaccine to Begin Clinical Testing
18 May 2010 Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Results in Patients With Prostate Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up